β-Blockers in Congenital Short-QT Syndrome as Ion Channel Blockers

Authors


  • The group of HA is supported by a grant of the Swiss National Science Foundation 310030_147060.

  • No disclosures.

Address for correspondence: Dr. Hugues Abriel, M.D., Ph.D., University of Bern, Department of Clinical Research, Murtenstrasse 35, 3010 Bern, Switzerland. Fax: +41-31-6320946; E-mail: Hugues.Abriel@dkf.unibe.ch

No abstract is available for this article.

Ancillary